The aim of this study was to clarify the hypothalamic neuropeptides that are associated with hyperphagic feeding in Tsumura Suzuki Obese Diabetes (TSOD) mice, a model of type 2 diabetes with polygenic abnormalities. TSOD mice showed an increase in body weight and hyperleptinemia from 1 month of age and hyperphagic feeding, hyperglycemia, hyperlipidemia and hyperinsulinemia from 3 to 12 months of age compared with age-matched non-diabetic control Tsumura Suzuki Non Obesity (TSNO) mice. The mRNA level of nucleobindin-2 (NUCB2), the precursor of the anorexigenic neuropeptide nesfatin-1, was significantly decreased in the hypothalamus of TSOD mice compared with that in TSNO mice from 3 to 12 months of age. The protein level of NUCB2 was significantly decreased in the hypothalamus of TSOD mice compared with that in TSNO mice at 3 months of age. The mRNA levels of galanin, melanin-concentrating hormone, neuropeptide Y, and pro-opiomelanocortin were significantly changed in the hypothalamus in TSOD mice at several time points. Another model of type 2 diabetes, db/db mice, which is a mutant mouse that lacks a functional leptin receptor, showed hyperphagic feeding but no change in hypothalamic NUCB2 mRNA compared with non-diabetic control db/ mice. The results suggest that the disrupted control of hypothalamic NUCB2-mediated signaling may contribute to hyperphagic feeding in TSOD mice. In addition, the mechanism for the development of hyperphagic feeding in TSOD mice is different than that in db/db mice.
Key words hyperphagic feeding; nucleobindin-2; hypothalamus; obesity; diabetesThe world-wide prevalence of obesity and type 2 diabetes mellitus (T2DM) is increasing, and genetic analyses in humans are difficult since these conditions are also associated with environmental factors. Therefore, model animals are highly useful in biomedical studies and may lead to new insights into human obesity and T2DM.1) Tsumura Suzuki Obese Diabetes (TSOD) mouse has been recently established as a model animal of obese T2DM by the selective breeding of ddY mice that show both obesity and urinary glucose.2) The adiposity and significantly higher body mass index in TSOD mice compared to those in non-diabetic control Tsumura Suzuki Non Obesity (TSNO) mice are detected as early as 4 weeks of age, and are maintained until at least 18 months of age.3,4) TSOD mice showed a high level of blood glucose after the intraperitoneal injection of glucose and a blunted glucosestimulated insulin secretion compared with TSNO mice.5) In addition, the hypoglycemic response to insulin treatment in TSOD mice was blunted compared to that in TSNO mice.
5)The insulin-stimulated uptake of 2-[ 3 H] deoxyglucose and translocation of glucose transporter-4 protein were impaired in skeletal muscle and adipose tissues in TSOD mice.6,7) Thus, TSOD mice have both increased resistance to insulin and decreased insulin secretion in response to glucose. Genome-wide screening in TSOD mouse for loci linked to body weight and glucose homeostasis indicated that obesity and hyperg...